These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10580203)

  • 1. Hepatitis A virus-specific humoral and cellular immune responses following immunization with a formalin-inactivated hepatitis A vaccine.
    Cederna JB; Klinzman D; Stapleton JT
    Vaccine; 1999 Dec; 18(9-10):892-8. PubMed ID: 10580203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity, safety and tolerability of varying doses and regimens of inactivated hepatitis A virus vaccine in Navajo children.
    Newcomer W; Rivin B; Reid R; Moulton LH; Wolff M; Croll J; Johnson C; Brown L; Nalin D; Santosham M
    Pediatr Infect Dis J; 1994 Jul; 13(7):640-2. PubMed ID: 7970954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine.
    Maiwald H; Jilg W; Bock HL; Löscher T; Sonnenburg F
    Vaccine; 1997 Mar; 15(4):346-8. PubMed ID: 9141202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does immunoglobulin interfere with the immunogenicity to Pasteur Mérieux inactivated hepatitis A vaccine?
    Zanetti A; Pregliasco F; Andreassi A; Pozzi A; Viganò P; Cargnel A; Briantais P; Vidor E
    J Hepatol; 1997 Jan; 26(1):25-30. PubMed ID: 9148018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saliva and serum as diagnostic media for antibody to hepatitis A virus in adults and in individuals who have received an inactivated hepatitis A vaccine.
    Laufer DS; Hurni W; Watson B; Miller W; Ryan J; Nalin D; Brown L
    Clin Infect Dis; 1995 Apr; 20(4):868-71. PubMed ID: 7795087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up immunogenicity of an inactivated hepatitis A virus vaccine in healthy children: results after 5 years.
    Fan PC; Chang MH; Lee PI; Safary A; Lee CY
    Vaccine; 1998; 16(2-3):232-5. PubMed ID: 9607035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell mediated and antibody immune response to inactivated hepatitis A vaccine.
    Schmidtke P; Habermehl P; Knuf M; Meyer CU; Sänger R; Zepp F
    Vaccine; 2005 Oct; 23(44):5127-32. PubMed ID: 16054733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
    Dagan R; Greenberg D; Weber F
    Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis A vaccine: persistence of antibodies 5 years after the first vaccination.
    Totos G; Gizaris V; Papaevangelou G
    Vaccine; 1997 Aug; 15(11):1252-3. PubMed ID: 9286052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivated hepatitis A vaccine in Chinese patients with chronic hepatitis B infection.
    Tsang SW; Sung JJ
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1445-9. PubMed ID: 10571600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactogenicity and immunogenicity of inactivated hepatitis A vaccines.
    Just M; Berger R
    Vaccine; 1992; 10 Suppl 1():S110-3. PubMed ID: 1362031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis A vaccine. A new convenient single-dose schedule with booster when long-term immunization is warranted.
    Victor J; Knudsen JD; Nielsen LP; Fomsgaard A; Thybo S; Bygbjerg I; Westh H
    Vaccine; 1994 Nov; 12(14):1327-9. PubMed ID: 7856299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of the immunogenicity of the inactivated hepatitis A vaccine Hep-A-in-vac from experimental and clinical data].
    Karpovich LG; Kalashnikova TV; Gorbunov MA; Pavlova LI; Bektimirov TA; Maĭdaniuk AG; Sandakhchiev LS; Levina VD; Ermolaeva TN; Rodomazova TA
    Vopr Virusol; 1995; 40(6):268-70. PubMed ID: 8686264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children.
    Castillo de Febres O; Chacon de Petrola M; Casanova de Escalona L; Naveda O; Naveda M; Estopinan M; Bordones G; Zambrano B; Garcia A; Dumas R
    Vaccine; 1999 Nov; 18(7-8):656-64. PubMed ID: 10547425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reactivity and immunogenicity of Havrix 360 vaccine for hepatitis A].
    Borcić B; Kovac S; Mihaljević I; Dobrovsak-Sourek V; Ljubicić M
    Lijec Vjesn; 1996; 118(7-8):162-4. PubMed ID: 8965633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and protectivity of a new liposomal hepatitis A vaccine.
    Ambrosch F; Wiedermann G; Jonas S; Althaus B; Finkel B; Glück R; Herzog C
    Vaccine; 1997 Aug; 15(11):1209-13. PubMed ID: 9286045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children.
    Balcarek KB; Bagley MR; Pass RF; Schiff ER; Krause DS
    J Infect Dis; 1995 Mar; 171 Suppl 1():S70-2. PubMed ID: 7876652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination against hepatitis A].
    Balli F; Di Biase AR; Viola L
    Pediatr Med Chir; 1996; 18(3):259-62. PubMed ID: 8966125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
    Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines.
    Van Herck K; Beutels P; Van Damme P; Beutels M; Van den Dries J; Briantais P; Vidor E
    J Med Virol; 2000 Jan; 60(1):1-7. PubMed ID: 10568755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.